Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMLA 5% for Tinnitus
NCT02266160Phase 4Completed
- Sponsor
- Emek Medical Center
- Start
- Nov 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Phase 4, randomised, double-blind trial in tinnitus comparing EMLA Cream with Placebo Cream (2 arms). Primary endpoints: Beck Depression Inventory at 4 days, Pittsburgh Sleep Quality Index at 4 days and 1 more. Started Nov 2014; status: completed.
02
Drugs
lidocaine + prilocaine
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT02266160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266160.